Lilly’s Covid-19 antibody combo EUA expands for post-exposure prophylaxis
The US Food and Drug Administration (FDA) has updated the Emergency Use Authorization (EUA) for Eli Lilly’s bamlanivimab plus etesevimab…
The US Food and Drug Administration (FDA) has updated the Emergency Use Authorization (EUA) for Eli Lilly’s bamlanivimab plus etesevimab…
Biocon Biologics, a Biocon subsidiary, has entered a strategic collaboration with Serum Institute of India unit Serum Institute Life Sciences…
Health Canada has granted full approval to Moderna and Pfizer-BioNTech Covid-19 vaccines, Spikevax (elasomeran mRNA vaccine) and Comirnaty respectively for…
BioMarin Pharmaceutical has received marketing authorisation from the European Commission (EC) for the use of Voxzogo (vosoritide) as a once…
Roche has decided to voluntarily withdraw Tecentriq (atezolizumab) as a treatment for PD-L1-positive unresectable locally advanced or metastatic triple-negative breast…
Pfizer has received provisional approval from Australia’s Therapeutic Goods Administration (TGA) for the use of its Covid-19 vaccine, Comirnaty, for…
Amgen is set to construct a new $365m product advanced assembly and packaging facility near Columbus, Ohio, expanding its manufacturing…
Germany-based STADA has agreed to acquire 16 consumer healthcare brands from Sanofi in 13 European markets, including Germany, France, Poland,…
RedHill Biopharma has reported initial findings from a preclinical study, which revealed that its drug candidate, opaganib (Yeliva, ABC294640), could…
The European Commission (EC) has approved Chugai Pharmaceutical’s Enspryng (satralizumab) to treat anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder…